Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy

Parkinson's Disease Clinical Trial

Official title:

Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT01989013
• Other study ID #: CST001
• Status: Enrolling by invitation
• Phase: N/A
• Start date: February 2014
• Est. completion date: March 2025

Study information

• Verified date: June 2023
• Source: Zia, Al Raza
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

We are studying & researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.

Description:

We are studying & researching the effect of CranioSacral I therapy on Parkinson's Disease

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 5
• Est. completion date: March 2025
• Est. primary completion date: March 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• must be Diagnosed with Parkinson's Disease

Exclusion Criteria:

• Anyone without Parkinson's Disease

Related Conditions & MeSH terms

• Parkinson Disease
• Parkinson's Disease

Intervention

Other:
• biweekly intervention
10 step craniosacral therapy protocol through manual therapy at feet , thoracic diaphragm, neck and cranium

Locations

Country	Name	City	State
United States	Naturalmed therapy	Ann Arbor	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
Zia, Al Raza

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Overall emotional State and sleep quality	will evaluate the overall emotional and sleeping habits on the measurement scale of 1-10 where 1 being emotionally stable and positive with 8 hours of quality sleep and 10 being emotionally unstable and have less than 4 hours of sleep at night and at the end of research will graphically and statistically provide the outcome of the above mentioned measure.	3 months
Primary	reduction in tremors due to Parkinson's disease in the patient	Measurement of the tremors and quality of the coordination of the medial leminiscus system on 1-10 (1 being zero tremors and 10 being out of control tremors) scale at the evaluation and at beginning and at the end of each treatment session and in the end will provide a graphical and statistical display in the change in the tremors relative to the therapeutic induction	3 months
Secondary	Quality of Proprioception	will evaluate the patients ability to move within space and time with certain precision and measure it on a scale of 1-10 (1 being very precise with fine motor movement and 10 being out of control fine motor movements)at the time of evaluation and at the beginning and end of each therapeutic treatment and finally document it graphically and statistically, the change in the overall motor movements like walking and quality of gait.	3 months